MedPath

Effect of Exercise on Cardiometabolic Risk Factors in Type II Diabetic Patients

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Behavioral: High-intensity interval training
Behavioral: Moderate intensity interval training
Registration Number
NCT04759469
Lead Sponsor
Cairo University
Brief Summary

Background: Physical activity is known to modify some of the diabetes risk factors; however, solid evidence is still needed to precisely know the optimum form of training best fits the individual needs of type II diabetic (T2D) patients.

Detailed Description

Objectives: the purpose of this study was to compare between high intensity interval training (HIIT) and moderate-intensity interval training (MIIT) effect on functional capacity (as a cardiorespiratory parameter), and on glucose control and glycated hemoglobin (HbA1C) (as metabolic parameters) in T2D patients, and to test exercise acceptability within these patients. Methods: 60 participants had participated in this study. Their ages ranged from 45 to 65 years. They were randomized into two equal groups (30/group); group (A) did HIIT and group (B) did MIIT. Both groups received 12 weeks of training. Measurements for six minute walking distance (6MWD), fasting blood glucose (FBG), and HbA1C levels were done before and after the study. Physical activity enjoyment scale (PACES) were filled by the patients by the end of the study; testing exercise enjoyment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Controlled type 2 diabetic patients who were clinically stable for at least 3 months before entering the study,
  • Aged 45-65 years
  • Non-smokers
  • body mass index (BMI) ranged between 20 to 39.9 Kg/m2
  • Fasting blood glucose ranged from (126-160) mg/dl
  • Sedentary lifestyle who didn't engage in physical activity for more than half an hour/ day for at least one month before entering the study.
Exclusion Criteria
  • unstable medical condition
  • smoker, recent surgery
  • Body mass index is more than 39.9 kg/m2 or less than 20 kg/m2
  • Any known musculoskeletal or neurological conditions that might interfere with the execution or the assessment of the exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-intensity interval training (HIIT)High-intensity interval trainingA high-intensity interval training program for 3 days/week (day after day) for 12 weeks on atreadmill (Biodex RTM500, Biodex Inc., New York), with a gradual increase in the program intensity.
Moderate intensity interval training (MIIT)Moderate intensity interval trainingA moderate intensity interval training program for 3 days/week (alternate days) on a treadmill (Biodex RTM500, Biodex Inc., New York), with a gradual increase in the program.
Primary Outcome Measures
NameTimeMethod
six minute walking distance (in meters)12 weeks

represent aerobic capacity (distance walked in 6 min)

Glycated Hemoglobin (HbA1C)12 weeks

Representing glucose control over 120 days

Fasting blood glucose12 weeks

Representing glucose level after 9 hours fasting

Exercise enjoyment and acceptability12 weeks

The Physical Activity Enjoyment Scale (PACES) score, out of 119. It is an 18-item scale that assesses enjoyment for physical activity by asking participants to rate "how you feel at the moment about the physical activity you have been doing" using a 7-point bipolar Likert scale, from 1 (I enjoy it) to 7 (I hate it). Eleven items were negatively worded and seven items were positively worded. After reverse scoring the 11negatively worded items, an overall enjoyment for physical activity score is determined by summing the items, with a range of 18-126 being possible. Higher scores indicate higher enjoyment.

Secondary Outcome Measures
NameTimeMethod
Adherence rates12 weeks

To what extent the patients will adhere to the exercise protocol

Trial Locations

Locations (1)

Alkasr Alaini hospital

🇪🇬

Cairo, AI Qahirah, Egypt

© Copyright 2025. All Rights Reserved by MedPath